column
A Modeling Study Recurrent Tuberculosis Towards End TB Strategy — China, 2025–2035
Tao Li, Xin Du, Zhongwei Jia, Yanlin Zhao
2024, 6(35): 885-890. DOI: 10.46234/ccdcw2024.189
Abstract FullText HTML PDF
Effectiveness of C-Reactive Protein as a Tuberculosis Screening Test Among HIV-Infected Individuals — Shanghai, China, 2021–2023
Lixin Rao, Zheyuan Wu, Jing Chen, Zhen Ning, Xin Shen
2024, 6(35): 891-895. DOI: 10.46234/ccdcw2024.190
Abstract FullText HTML PDF
Evaluation of Latent Tuberculosis Infection Using the ESAT6-CFP10 Skin Test Among International Freshmen With Diverse Skin Tones at a University — Nanjing City, Jiangsu Province, China, September 2023
Peng Lu, Rong Wang, Jingjing Xu, Jianming Wang, Fangfang Du, Guozhi Wang, Shiming Cheng, Limei Zhu
2024, 6(35): 896-900. DOI: 10.46234/ccdcw2024.191
Abstract FullText HTML PDF
The Implications of Artificial Intelligence on Infection Prevention and Control: Current Progress and Future Perspectives
Lin Yang, Shuya Lu, Lei Zhou
2024, 6(35): 901-904. DOI: 10.46234/ccdcw2024.192
Abstract FullText HTML PDF